Logo image of MKEA.PA

MAUNA KEA TECHNOLOGIES (MKEA.PA) Stock Price, Quote, News and Overview

EPA:MKEA - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR

0.62  0 (0%)

MKEA.PA Quote, Performance and Key Statistics

MAUNA KEA TECHNOLOGIES

EPA:MKEA (8/7/2023, 7:00:00 PM)

0.62

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High0.92
52 Week Low0.4
Market Cap28.74M
Shares46.35M
Float48.32M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-05 2011-07-05


MKEA.PA short term performance overview.The bars show the price performance of MKEA.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6

MKEA.PA long term performance overview.The bars show the price performance of MKEA.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of MKEA.PA is 0.62 EUR. In the past month the price decreased by -3.43%. In the past year, price decreased by -29.47%.

MAUNA KEA TECHNOLOGIES / MKEA Daily stock chart

MKEA.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 28.22 207.98B
IUI1.DE INTUITIVE SURGICAL INC 73.65 179.25B
1ISRG.MI INTUITIVE SURGICAL INC 73.56 178.94B
BSX.DE BOSTON SCIENTIFIC CORP 38.58 136.96B
2M6.DE MEDTRONIC PLC 16.42 100.04B
SHL.DE SIEMENS HEALTHINEERS AG 21.68 55.04B
BOX.DE BECTON DICKINSON AND CO 12.46 44.79B
1BDX.MI BECTON DICKINSON AND CO 11.65 41.87B
EWL.DE EDWARDS LIFESCIENCES CORP 28.98 39.36B
DC4.DE DEXCOM INC 52.28 30.13B
PHIA.AS KONINKLIJKE PHILIPS NV 16.15 20.65B
PHI1.DE KONINKLIJKE PHILIPS NV 16.1 20.58B

About MKEA.PA

Company Profile

MKEA logo image Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 56 full-time employees. The company went IPO on 2011-07-05. The firm focuses on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product is Cellvizio, a confocal laser endomicroscopy platform using microprobes and needles. This technological platform enables to view tissues at cellular level, in real time, during standard procedure. Cellvizio can be used in gastroenterology, pulmonology, or urology. The firm markets its technological platform in more than 40 countries, including the United States, Europe, Japan, China, South Korea as well as several Latin American countries.

Company Info

MAUNA KEA TECHNOLOGIES

9, rue d'Enghien

Paris ILE-DE-FRANCE FR

Employees: 56

MKEA Company Website

Phone: 33148240345.0

MAUNA KEA TECHNOLOGIES / MKEA.PA FAQ

What is the stock price of MAUNA KEA TECHNOLOGIES today?

The current stock price of MKEA.PA is 0.62 EUR.


What is the ticker symbol for MAUNA KEA TECHNOLOGIES stock?

The exchange symbol of MAUNA KEA TECHNOLOGIES is MKEA and it is listed on the Euronext Paris - Matif exchange.


On which exchange is MKEA.PA stock listed?

MKEA.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for MAUNA KEA TECHNOLOGIES stock?

8 analysts have analysed MKEA.PA and the average price target is 1.99 EUR. This implies a price increase of 220.81% is expected in the next year compared to the current price of 0.62. Check the MAUNA KEA TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MAUNA KEA TECHNOLOGIES worth?

MAUNA KEA TECHNOLOGIES (MKEA.PA) has a market capitalization of 28.74M EUR. This makes MKEA.PA a Nano Cap stock.


How many employees does MAUNA KEA TECHNOLOGIES have?

MAUNA KEA TECHNOLOGIES (MKEA.PA) currently has 56 employees.


What are the support and resistance levels for MAUNA KEA TECHNOLOGIES (MKEA.PA) stock?

MAUNA KEA TECHNOLOGIES (MKEA.PA) has a support level at 0.61 and a resistance level at 0.62. Check the full technical report for a detailed analysis of MKEA.PA support and resistance levels.


Is MAUNA KEA TECHNOLOGIES (MKEA.PA) expected to grow?

The Revenue of MAUNA KEA TECHNOLOGIES (MKEA.PA) is expected to decline by -18.48% in the next year. Check the estimates tab for more information on the MKEA.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MAUNA KEA TECHNOLOGIES (MKEA.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MAUNA KEA TECHNOLOGIES (MKEA.PA) stock pay dividends?

MKEA.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of MAUNA KEA TECHNOLOGIES (MKEA.PA)?

MAUNA KEA TECHNOLOGIES (MKEA.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).


MKEA.PA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to MKEA.PA. When comparing the yearly performance of all stocks, MKEA.PA is a bad performer in the overall market: 84.84% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MKEA.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to MKEA.PA. MKEA.PA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MKEA.PA Financial Highlights

Over the last trailing twelve months MKEA.PA reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 28.86% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%24.82%
Sales Q2Q%-6.79%
EPS 1Y (TTM)28.86%
Revenue 1Y (TTM)-2.87%

MKEA.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 88% to MKEA.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -62.13% and a revenue growth -18.48% for MKEA.PA


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts87.5
Price Target1.99 (220.97%)
EPS Next Y-62.13%
Revenue Next Year-18.48%